Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a …


Install CouponFollow Chrome Extension   CouponFollow Extension

$225
OFF

Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

1 week from now

BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a …

seaporttx.com

$225
OFF

PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...

1 week from now

BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven …

businesswire.com

$225
OFF

Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

1 week from now

Oct 21, 2024  · Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round. Financing led by General Atlantic with participation from T. Rowe Price Associates, …

businesswire.com

$225
OFF

PureTech Founded Entity Seaport Therapeutics Closes $225

1 week from now

Oct 21, 2024  · Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round. Financing led by General Atlantic with participation from T. Rowe Price Associates, …

biospace.com

$225
OFF

Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

1 week from now

BOSTON, October 21, 2024 -- (BUSINESS WIRE)--Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel …

yahoo.com

7%
OFF

PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...

1 week from now

Oct 21, 2024  · Following the Series B financing, PureTech will hold equity ownership in Seaport of 36.7% on a diluted basis. The financing brings the total capital raised by Seaport to $325 …

streetinsider.com

$225
OFF

Seaport Therapeutics Closes $225M Series B Financing Round

1 week from now

Oct 21, 2024  · Seaport Therapeutics, a Boston, MA-based biopharmaceutical company that is developing novel neuropsychiatric medicines, raised $225M in Series B funding. The round, …

finsmes.com

$225
OFF

Seaport Therapeutics Secures US$225 Series B Funding To Develop ...

1 week from now

Oct 23, 2024  · The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform originally developed by Monash University, has announced the …

monash.edu

$225
OFF

PureTech's Seaport Closes $225m Series B Round

1 week from now

Oct 21, 2024  · PureTech Health announced on Monday that Seaport Therapeutics, a company it founded, has closed an oversubscribed $225m series B financing round. The FTSE 250 …

sharecast.com

$225
OFF

Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

1 week from now

Oct 21, 2024  · BOSTON-- (BUSINESS WIRE)--Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel …

biospace.com

7%
OFF

Seaport Therapeutics Closes $225 Million Series B Financing …

1 week from now

Oct 21, 2024  · Seaport Therapeutics successfully closes a $225 million Series B financing round, marking a total capital of $325 million since its launch in April 2024. PureTech retains 36.7% …

venturecapital.com

$225
OFF

PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...

1 week from now

BOSTON, October 21, 2024 – Seaport Therapeutics (“Seaport”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven …

ft.com

$225
OFF

PureTech Founded Entity Seaport Therapeutics Closes $225 Million ...

1 week from now

Oct 21, 2024  · PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport …

marketscreener.com

$225
OFF

Seaport Therapeutics Closes $225 Million Financing

1 week from now

Oct 21, 2024  · Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in …

thepharmaletter.com

$225
OFF

Seaport Therapeutics Raises $225 Million In Series B Financing

1 week from now

Oct 29, 2024  · The WilmerHale team representing Seaport consisted of Stuart Falber, Riley O’Brien and Emily Ivers. On October 21, 2024, Seaport Therapeutics, a clinical-stage …

wilmerhale.com

$225
OFF

Seaport Eyes Platform, Pipeline Growth With $225M Series B

1 week from now

Oct 21, 2024  · Seaport Therapeutics said today it has closed on an oversubscribed $225 million Series B financing, with the proceeds set to be used toward enhancing its Glyph™ technology …

genengnews.com

$225
OFF

Seaport Therapeutics Closes $225 Million Oversubscribed Series B ...

1 week from now

Oct 21, 2024  · Tweet. Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven …

tmcnet.com

$225
OFF

Seaport Docks $225m For Its Improved Neuropsychiatry Drugs

1 week from now

6 days ago  · Seaport Therapeutics completes a $225m Series B to fund ... Series A in April, Seaport Therapeutics has moved swiftly to shore up its finances with a $225 million second …

pharmaphorum.com

$225
OFF

PRTC's Seaport Closes $225M Series B Financing

1 week from now

BOSTON, October 21, 2024 - Seaport Therapeutics ("Seaport"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven …

londonstockexchange.com

$225
OFF

PRTC's Seaport Closes $225M Series B Financing

1 week from now

21 October 2024. 21 October 2024. PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round. Financing led by General Atlantic with …

sharesmagazine.co.uk

FAQs about Seaport Therapeutics Closes $225 Million Oversubscribed Series B ... Coupon?

Who is seaport Therapeutics?

Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. The Company has a proven strategy of advancing clinically validated mechanisms previously held back by limitations that are overcome with its proprietary Glyph technology platform. ...

How much money did seaport raise in 2024?

Founding investors ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, and co-founder PureTech Health also participated. The financing brings the total capital raised by Seaport to $325 million since the Company’s launch in April 2024. ...

What is seaport's glyph platform?

The programs in Seaport’s pipeline use the Glyph platform, which is designed to enable and enhance oral bioavailability, avoid first-pass metabolism and reduce liver enzyme elevations or hepatotoxicity and other side effects to advance clinically active drugs that were previously hindered by those limitations. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension